‘Exercise pill’ that may reduce appetite and mimic physical activity clears first human test
Gym haters, rejoice — the workout of the future may not require breaking a sweat. Biotech company Enveda announced this week that its experimental drug, designed to curb appetite and mimic some of the body’s effects of physical activity, delivered encouraging results in its first clinical trial. “ENV-308 is our attempt to put the chemistry … Read more